Long-term outcomes in patients who underwent surgical correction for atrioventricular septal defect by Ayabakan, Canan et al.
Address for correspondence: Dr. Özlem Sarısoy, Başkent Üniversitesi İstanbul Sağlık Uygulama ve Eğitim Hastanesi, Çocuk Kardiyoloji Bilim Dalı, 
Kirazlıdere Mah. Parkverde Sitesi A6/1 D:5 Çekmeköy İstanbul-Türkiye
Phone: +90 532 744 08 90  E-mail: ozlemsarisoy@yahoo.com
Accepted Date: 12.07.2018  Available Online Date: 11.09.2018
©Copyright 2018 by Turkish Society of Cardiology - Available online at www.anatoljcardiol.com
DOI:10.14744/AnatolJCardiol.2018.39660
Original Investigation 229
 Özlem Sarısoy,  Canan Ayabakan,  Kürşad Tokel*,  Murat Özkan**,  Rıza Türköz1,  Sait Aşlamacı**
Departments of Pediatric Cardiology and 1Cardiovascular Surgery, 
Başkent University İstanbul Health and Education Hospital; İstanbul-Turkey
Departments of *Pediatric Cardiology and **Cardiovascular Surgery, Başkent University Ankara Hospital; Ankara-Turkey
Long-term outcomes in patients who underwent surgical correction 
for atrioventricular septal defect
Introduction
Atrioventricular septal defect (AVSD) constitutes 4%–5% of 
all the congenital heart defects. Complete AVSD is the most fre-
quently encountered form in Down syndrome (1).
Recent studies have demonstrated markedly improved sur-
vival in AVSD after operative repair. The surgical mortality is re-
duced to 3%–8%, and the 20 year-survival rate is as high as 95% 
(2-7). In about a quarter of these patients, reoperations, which 
are mostly due to late complications like left atrioventricular (AV) 
valve insufficiency and left ventricular outflow tract obstruction 
(LVOTO), continue to be the main concern. 
The aim of this retrospective study was to assess the early 
and long-term follow-up results of children who underwent sur-
gery due to AVSD, and to analyze the major risk factors for mor-
bidity and mortality postoperatively.
Methods
The patient database was retrospectively scanned to iden-
tify all children who were diagnosed with AVSD, and had been 
operated during 1996–2016 at Başkent University. Only patients 
with balanced ventricles and without accompanying cardiac 
anomalies were eligible for inclusion. Any patient with multiple 
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ventricular septal defects (VSDs), pulmonary stenosis, aortic 
coarctation, Fallot tetralogy, double outlet, or discordant ven-
triculoarterial connections were excluded. The study group 
comprised 496 patients. Following details were noted from the 
patient records: the age and weight at operation, presence of 
Down syndrome, preoperative catheterization data [emphasiz-
ing the pressure measurements, pulmonary vascular resistance 
(PVR) and flow ratios] surgical technique, surgical details (cardio-
pulmonary bypass and aortic cross-clamp times), details of the 
postoperative intensive care [durations of postoperative ventila-
tion support, inotropic treatment, and stay in the intensive care 
unit (ICU)], total hospital stay, complications (infections, postoper-
ative arrhythmias, and reoperations), operative and late mortality.
For patients with a risk of postoperative pulmonary hyperten-
sion, the pulmonary artery pressure was monitored in the ICU. If 
the patient had preoperative PVR >2 Wood units and/or pulmonary 
artery pressure >40 mm Hg or was older than 6 months, a catheter 
was intraoperatively placed in the main pulmonary artery.
Echocardiographic data with an emphasis on AV valve insuf-
ficiency and LVOTO was also preoperatively recorded at dis-
charge and during the last visit. Rastelli classification was used 
to describe the morphology of the AV valve in patients with com-
plete AVSD.
To analyze the changes in consecutive time that could pos-
sibly affect the outcome, follow-up period was arbitrarily divided 
into three phases considering the date of the operation. Each 
operation phase was 5 years in duration and was designated 
as 1996–2001 (first phase), 2002–2007 (second phase), and 2008–
2016 (third phase).
Statistical analysis
All analyses were performed using the Statistical Pack-
age for the Social Sciences software (version 20 for Windows; 
SPSS, Chicago, IL, USA). Continuous variables were reported as 
mean±standard deviation of the mean, and categorical variables 
were presented as frequencies and percentages. Univariate com-
parisons of continuous variables were made using t-test. Categori-
cal variables were compared using X2 test. A two-sided p value 
less than 0.05 was considered statistically significant. Binary lo-
gistic regression analysis was used to examine the relationship 
between potential risk factors and early mortality. Results are 
shown as odds ratios (ORs) with 95% confidence intervals (CI). Lo-
gistic regression analysis, using all variables in stepwise method, 
was performed to identify independent risk factors. Cox propor-
tional hazard models were used to examine the predictors for re-
operation. Results are shown as a hazard ratio (HR) with 95% CI.
Results
There were 215 male (43.3%) and 281 female (56.7%) patients. 
A total of 240 patients (48.4%) were diagnosed with Down syn-
drome. Of all the patients, 63.4% (314 patients) had complete 
AVSD, and 36.6% (181 patients) had intermediate-partial AVSD. 
The mean age of patients with complete AVSD was 10.01±12.01 
(range, 2–84; median, 6; 25 and 75 percentiles, 5 and 9, respec-
tively) months. The mean age of patients with partial-interme-
diate AVSD was 46.59±44.01 (range, 2–240; median, 30; 25 and 
75 percentiles, 17 and 63, respectively) months. The mean body 
weight during the operation was 9.26±8.25 (range, 2.5–64) kg.
Atrial septal defect (ASD) and patent ductus arteriosus (PDA) 
were observed in 26.2% of the patients. Rastelli type A morphol-
ogy was seen in 92.2% of the patients with complete AVSD 
whereas 6.5% had type B and 1.3% had type C morphology. 
Twelve patients (2.4%) had pulmonary banding prior to to-
tal correction. AVSD closure technique used was single-patch 
in 108 patients (21.8%), modified single-patch (Wilcox technique) 
in 260 patients (52.4%), and double-patch in 128 patients (25.8%).
The early postoperative morbidity and mortality within first 
month were calculated as 38% and 10%, respectively. Common 
causes of early morbidity were pericardial effusion (38 patients), 
pneumonia (30 patients), pleural effusion (21 patients), and sub-
glottic edema and stenosis due to prolonged intubation (19 pa-
tients). A total of 48 patients died in the first postoperative month. 
Death within 24 h was due to hemodynamic instability and was 
observed in 28 patients. Early mortality beyond 24 h was seen in 
the remaining patients due to cardiac failure, pulmonary hyper-
tensive crisis, arrhythmia, or septicemia.
Postoperative infections, confirmed by blood, urine, or tra-
cheal aspirate cultures, were seen in 21% of the patients. 
Pulmonary artery pressure catheter was placed in 189 pa-
tients, of which 78 had pulmonary hypertensive crisis (15.7%) 
and 3 died. No complications related to the placement or remov-
al of the catheters was noted. 
There was postoperative third-degree AV block in 64 patients 
(12.9%). Only 12 patients had permanent block and had perma-
nent cardiac pacemaker implanted.
Morbidity and mortality observed beyond 1 month was con-
sidered a late result, and the rates were calculated as 13.1% 
and 1.9%, respectively. The most prevalent cause of morbidity 
was reoperation (8.9%; 44 patients). Other causes were cardiac 
failure (2.6%; 13 patients), upper airway obstruction due to sub-
glottic stenosis (1%; 5 patients), and infection (0.8%; 4 patients). 
Among 44 patients who were reoperated, 12 patients had 
undergone mitral valve repair (2.4%) and 18 patients had under-
gone mitral valve replacement (3.6%). LVOTO developed in 19 pa-
tients postoperatively, among which 10 (2%) were operated. Two 
patients had undergone residual VSD closure, and one patient 
had aortic coarctation repair. In two patients, the residual patent 
ducts were postoperatively closed with coils. 
Considering the echocardiographic results at discharge, no 
correlation was observed between the surgical technique and 
degree of left AV valve insufficiency (p=0.67). However, the AV 
valve insufficiency degree measured at the last follow up echo-
cardiography was significantly lower in the double patch group 
(p=0.002).
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Left ventricular outflow tract obstruction 
Among 19 patients who had late postoperative LVOTO, 14 
patients had undergone repair using Wilcox technique, 4 pa-
tients with double-patch, and 1 patient with single-patch tech-
nique. Although Wilcox technique was more frequent among 
patients with LVOTO, the correlation between surgical technique 
and LVOTO was not significant (p=0.11). Additionally, the type of 
AVSD (complete vs. partial AVSD) was not related to develop-
ment of LVOTO (p=0.31).
Early mortality
We tested the following possible risk factors for early mortal-
ity in patients with postoperative AVSD: age, body weight, Down 
syndrome presence, degree of preoperative and postoperative 
left AV valve insufficiencies, type of AVSD, surgical technique, 
and the surgical era. Even though each of these factors were 
significant models according to binary logistic regression analy-
sis (p<0.001), only low body weight was found to have significant 
correlation with early mortality (p=0.018). The assessment of risk 
factors for early mortality using binary logistic regression analy-
sis is given in Table 1.
The early mortality in complete AVSD group was determined 
as 12.5%, whereas in the partial-intermediate group it was 5.5%. 
When comparison analysis was made with respect to early 
mortality; having younger age and lower body weight at opera-
tion, complete AVSD, postoperative arrhythmia, pulmonary hy-
pertension, high PVR and pulmonary hypertensive crisis were 
significantly related with early mortality (p<0.01). On the other 
hand, the degree of preoperative or postoperative left AV valve 
insufficiency, Down syndrome presence, or infections were not 
significantly related with early mortality.
Early postoperative mortality for the three time phases were 
calculated as 13% (between first phase), 9.9% (second phase), 
and 9.4% (third phase), whereas the overall mortality was 10%. 
The decrease in mortality was significant after the first phase, 
and the correlation between the surgical era and mortality was 
found as statistically significant (p=0.036). Low body weight was 
found to be a risk factor for early mortality in each phase (p<0.05).
The late mortality was 1.9% (nine patients), and all patients 
died because of progressive cardiac failure.
Reoperation
The assessment of risk factors for reoperation using Cox 
regression analysis is given in Table 2. The factors determined 
as significant risk factors for reoperation for valve repair were 
severe preoperative or postoperative left AV valve insufficiency 
and early surgical era (higher risk in the first phase) (p<0.05 for 
each). On the other hand, surgical era, age, and body weight 
were significantly related to reoperation for LVOTO. 
The rates of reoperations were significantly high in patients 
with partial AVSD and those operated with Wilcox technique 
(p=0.001) as well. 
Down syndrome and complete AVSD
Patients with Down syndrome were young and light-weight-
ed during operation. They had more preoperative pulmonary 
hypertension, higher PVR, (CPB), aortic cross-clamp, and venti-
lation and inotropic support than patients not affected by Down 
syndrome. They also had more frequent infections (Table 3) than 
those without Down syndrome.
Because Down syndrome was significantly more frequent 
among patients with complete AVSD than partial AVSD, similar 
findings were pertinent for patients with complete AVSD as well 
(Table 4).
Although overall early morbidity was more frequent in Down 
syndrome, patients without Down syndrome had more frequent 
and higher degree of left AV valve insufficiency at their last visit. 
This also resulted as a higher rate of mitral valve repair and mi-
tral valve replacement. 
Therefore, higher late morbidity in patients without Down 
syndrome may be attributed to the fact that AV valve complica-
tions and reoperations were more frequent among patients in 
the partial/intermediate AVSD group.
Discussion
In our retrospective study of 496 patients with AVSD, who 
were postoperatively followed for up to 20 years in a tertiary 
health center, we observed a decrease in early mortality from 
13% to 9.9% after 2001. This was parallel to the rate of reopera-
Table 1. Assessment of risk factors for early mortality 
using Binary logistic regression analysis
Variable Early mortality P value
 OR (95% CI)
Down 2.18 (0.54-8.85) 0.272
Preop left AV valve insufficiency 0.74 (0.20-2.75) 0.659
Type of AVSD 0.48 (0.69-3.35) 0.461
Years of operation  0.936
1996–2001 1
2002–2007 0.86 (0.74-10.05) 0.905
2008–2016 0.71 (0.11-4.34) 0.717
Associated cardiac anomalies 1.49 (0.34-6.56) 0.592
Age 1.00 (0.83-1.22) 0.931
Weight  0.44 (0.22-0.86) 0.017
Cleft closure 1.41 (0.11-17.93) 0.791
Technique 0.10 (0.11-1.03) 0.053
Postop left AV 1.30 (0.35-4.71) 0.688
valve insufficiency
AV – atrioventricular, AVSD – atrioventricular septal defect, CI – confidence interval, 
OR – odds ratio
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tion that declined from 13% to 5.9% (p=0.012). Within past 20 
years, the surgical success of AVSD has increased due to our 
better understanding of the defect structure, advanced myocar-
dial protection and perfusion methods, increased use of periop-
erative transesophageal echocardiography, and better postop-
erative care. 
Our results are concordant with the literature, in which more 
than 20-year experience is presented. Similarly in the reported 
studies, the mortality has been reported as high as 15%–20% in 
the first year, which has significantly decreased to 5.7%–10% in 
the following years (2-8). Crawford and Stroud (8) have reported 
current mortality as 3%–6%. The authors listed the factors that 
led to the drop in the mortality as performing early surgery (be-
fore pulmonary hypertension develops), encountering less post-
operative low cardiac output syndrome, decline in the rate of 
hemodynamically important residual defects, and third-degree 
AV block. In the study by Hoohenkerk et al. (2), early mortality 
was reported to decrease from 16% to 8.3% in 30 years. They 
also similarly reported higher mortality in patients with complete 
AVSD. Their mortality in the complete AVSD group were 10.5% 
compared with 3.9% in the partial-intermediate group. The cor-
responding rates in our study were 12.5% and 5.5%, respectively. 
The median age of our patients with complete AVSD during 
operation was 6 months. Therefore, we relate higher mortality 
in our cohort to older age at operation. In patients with AVSD, 
pulmonary arterial pressure and PVR increase with time (9). In 
these patients, pulmonary hypertensive crisis is a known risk 
factor for early mortality. We also observed postoperative pul-
Table 2. Assessment of risk factors for reoperation using Cox regression analysis
Variable Reoperation P value Valve op P value LVOTO P value
 HR (95%CI)  HR (95% CI)  HR (95% CI)
Down 0.49 (0.17-1.41) 0.191 0.84 (0.21-3.37) 0.812 0.45 (0.11-1.85) 0.271
Preoperative left AV  0.048  0.050  0.767
valve insufficiency
Minimal 1 0.754 1 0.801  1
Mild 1.41 (0.16-12.41) 0.787 0.73 (0.06-7.90) 0.410  0.950
Moderate 0.74 (0.08-6.36) 0.402 0.37 (0.03-3.85) 0.615  0.952
Severe 2.43 (0.30-19.60)  1.76 (0.19-16.24)   0.948
Type of AVSD 0.51 (0.20-1.28) 0.155 0.17 (0.04-0.64) 0.009 0.68 (0.16-2.88) 0.603
Years of operation  0.008  0.074  0.004
1996–2001 1 0.014 1 1 1 0.001
2002–2007 0.21 (0.06-0.72) 0.003 0.68 (0.14-3.28) 0.635 0.002 (0.00-0.09) 0.054
2008–2016 0.22 (0.08-0.60)  0.27 (0.76-0.96) 0.043 0.20 (0.04-1.02)
Associated cardiac anomalies 1.30 (0.63-2.68) 0.476 1.44 (0.55-3.75) 0.452 1.00 (0.33-3.00) 0.987
Age 0.99 (0.95-1.02) 0.686 1.03 (0.99-1.078) 0.098 0.88 (0.81-0.97) 0.009
Weight  1.03 (0.89-1.18) 0.663 0.82 (0.65-1.03) 0.095 1.37 (1.07-1.76) 0.012
Cleft closure 0.48 (0.10-2.31) 0.366 0.30 (0.03-2.62) 0.279 2.12 (0.18-23.94) 0.541
Technique 1.26 (0.59-2.68) 0.549 2.13 (0.50-9.03) 0.303 1.46 (0.60-3.57) 0.403
Postop left AV valve insufficiency 1.90 (1.25-2.88) 0.002 3.26 (1.87-5.66) 0.000 0.49 (0.23-1.05) 0.067
AV – atrioventricular, AVSD – atrioventricular septal defect, CI – confidence interval, HR – hazard ratio, LVOTO - left ventricular outflow tract obstruction
Table 3. Comparison of patients with Down syndrome and 
those without Down syndrome
 Down syndrome Not affected by P value
 (n=240) Down syndrome
  (n=256)
Age (months) 14.54±22.61 31.59±39.09 <0.001
Weight (kg) 7.14±6.12 11.24±9.43 <0.001
PAP 38.59±11.88 28.17±12.12 <0.001
PVR 2.21±1.86 1.67±1.37 <0.001
CPB time (min) 99.66±29.41 88.50±40.51 0.01
Aortic cross-clamp 71.61±20.27 60.72±25.13 0.01
time (min)
Inotrop time (day) 4.34±4.12 3.13±5.50 <0.001
MV duration (h) 83.79±228.22 43.40±109.15 0.02
PAP - pulmonary arterial pressure, PVR - pulmonary vascular resistance, CPB - 
cardiopulmonary bypass, MV - mechanical ventilation
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monary hypertensive crisis as an important risk factor for early 
mortality, which is especially prevalent in patients with complete 
AVSD. Because patients with complete AVSD comprise the ma-
jority of our cohort, the mortality might have been influenced by 
patient distribution as well. 
We prefer to operate on patients with complete AVSD before 
3–4 months and patients with partial AVSD at approximately 2 
years of age. However, in this cohort, most of the patients with 
complete AVSD were referred late for operation, especially dur-
ing the earliest surgical era; hence, our median age for operation 
was significantly increased.
Younger age and lower weight at operation, especially for 
patients with partial/intermediate AVSD, during the early surgi-
cal era were the other significant risk factors for early mortality.
The rate of reoperation for AVSDs has been reported as 5%–
15% (5, 8, 10). The most common cause for reoperation was left 
AV valve insufficiency followed by LVOT stenosis (5, 8, 10). The 
rate of reoperation in our cohort was 8.9%, and the reoperations 
mainly were mitral valve replacement or mitral repair. Operations 
directed to LVOT stenosis comprised only a fifth of all reopera-
tions. The degree of preoperative and postoperative left AV valve 
insufficiencies and the earlier surgical era seem to be significant 
in terms of reoperation. In our study, valve operations were more 
frequent among patients with partial/intermediate AVSD, in which 
the degree of residual regurgitation is higher probably due to un-
sewn cleft in the left AV valve. Partial AVSD was more frequent 
among patients without Down syndrome, which is why one can 
assume that these patients had more frequent valve reoperations.
Because of the favorable anatomy, modified single-patch 
(Wilcox) technique is usually the preferred operation in partial 
or intermediate AVSDs. It is performed by directly suturing the 
common AV valve leaflet to the crest of the ventricular septum. 
In this technique, directly pulling the AV valve leaflets down to 
the crest causes crowding of the LVOT and has the potential for 
LVOTO. This is why double-patch technique is usually claimed 
to be a better alternative because the patch used to close the 
ventricular component of the AVSD helps widen the LVOT. Fur-
thermore, in Wilcox technique, the AV valve drawn down to the 
septum has a non-physiological height of hinge point that also 
causes concern for potential residual VSD and left AV valve in-
sufficiency. On the other hand, this simpler technique has the 
advantage of not having the need to divide the AV valves (11, 12). 
We also preferred Wilcox technique in our patients with partial 
AVSD. This may be another reason why valvular reoperations 
were more frequent among these patients.
In our study group, LVOTO was more frequently patients op-
erated with Wilcox technique, but this did not reach statistical 
significance. Other risk factors for LVOTO were earlier surgical 
era, younger age, and lower body weight at operation. In the 
study conducted by Ginde et al. (5), Wilcox technique was not 
found to be a risk factor in reoperation for LVOTO, but it was a 
risk factor for residual VSD. Residual VSD was an infrequent 
finding in our study regardless of the operation technique; only 
two patients were reoperated due to residual VSD. 
Early morbidity was high in patients with Down syndrome. 
Even though they underwent successful cardiac surgery, the 
recovery time and the rate of complications are influenced by 
the co-morbid factors in these patients. Most of them have com-
plete AVSD, high pulmonary artery pressure, and PVR. They also 
have long aortic cross-clamp and CPB times that may explain 
the longer postoperative inotropic support and mechanical ven-
tilator support times. However, early mortality was not affected 
by Down syndrome presence. Remarkably, late morbidity was 
higher in patients not affected by Down syndrome, which was 
mostly related to the high rate of left AV valve insufficiency and 
more frequent valve-related reoperations. 
Comparing these results to those previously reported, there 
are studies stating that total correction operations in patients 
with Down syndrome, if performed early, and have similar mor-
tality and morbidity risks compared to patients not affected by 
Down syndrome (2, 5, 6, 8, 10, 13). Nevertheless it is important 
to indicate that our patients with complete AVSD were relatively 
old during operation that might have created the difference in 
terms of mortality and mortality.
Study limitation
The study was limited by its retrospective nature. Although 
all patients had clear documentation of preoperative and post-
operative variables. Additionally, some patients have short fol-
low-up. Because these patients continued follow-up at centers 
near their country.
Table 4. Comparison of patients with complete-partial 
atrioventricular septal defect
 cAVSD pAVSD P value
 (n=315) (n=181)
Age (months) 9.99±11.99 46.59±44.01 <0.001
Weight (kg) 5.99±2.63 14.94±11.14 <0.001
PAP 39.12±11.46 22.85±8.51 <0.001
PVR 2.18±1.81 1.50±1.19 <0.001
CPB 106.78±35.24 71.53±24.44 <0.001
Aortic cross-clamp 76.35±18.92 47.99±19.57 <0.001
Inotrop duration 4.57±4.82 2.25±4.77 <0.001
(days)
Inotrop score 18.42±65.81 5.82±11.21  0.001
MV duration (h) 87.95±217.79 20.34±44.84 <0.001
ICU stay (days) 9.40±17.53 3.96±9.19 <0.001
Time to discharge 14.72±22.81 6.83±4.00 <0.001
(days)
AVSD - atrioventricular septal defect, PAP - pulmonary arterial pressure, PVR - 
pulmonary vascular resistance, CPB - cardiopulmonary bypass, MV - mechanical 
ventilation, ICU - intensive care unit
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Conclusion
Although the morbidity and mortality of AVSD operations are 
lower in recent years, the frequency of reoperations is still high. 
More frequently encountered left AV valve insufficiency in pa-
tients with partial AVSD rationalizes the high rate of valve-relat-
ed reoperations in this group. Although Down syndrome is not a 
risk factor for early mortality, it causes high risk of morbidities, 
such as longer postoperative ventilation and inotropic support. 
The frequency of pulmonary hypertension and the consequent 
complications are also high in patients with Down syndrome. The 
optimal surgical technique for AVSD repair still remains a vexed 
question. Further research is warranted to determine whether 
any surgical technique (i.e. Wilcox technique as suggested in our 
study) is an important risk factor for long-term morbidities in pa-
tients undergoing surgical correction for AVSD.
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